Company: LCTX
Filing Date: 2025-08-15
Form Type: S-8
Source: 0000950170-25-109396
Chunk: 1

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-08-15
Form: S-8
Chunk 1
---
 Plan”). At Lineage’s annual meeting of shareholders held on June 26, 2025, Lineage’s shareholders approved an amendment to the 2021 Plan to increase the number of common shares reserved for issuance thereunder by 19,500,000.

Lineage filed with the Commission: (a) a Registration Statement on Form S-8 on September 28, 2021 (File No. 333-259853) (the “2021 Registration Statement”) to register an aggregate of 30,358,599 common shares available for issuance under the 2021 Plan, consisting of (i) 15,000,000 shares and (ii) an estimated 15,358,599 Prior Plan Returning Shares (as defined in the 2021 Plan); and (b) a Registration Statement on Form S-8 on November 13, 2023 (File No. 333-275505) (the “2023 Registration Statement” and together with the 2021 Registration Statement, the “Prior Registration Statements”) to register an additional 19,500,000 common shares for issuance under the 2021 Plan.

This Registration Statement registers an additional 19,500,000 common shares for issuance under the 2021 Plan, thereby increasing the total number of common shares available for issuance under the 2021 Plan to an amount not to exceed the sum of (i) 54,000,000 shares and (ii) the Prior Plan Returning Shares, if any, as such shares become available from time to time.

This Registration Statement relates to securities of the same class as those registered under the Prior Registration Statements and is being filed in accordance with General Instruction E to Form S-8. Pursuant to such instruction, the contents of the Prior Registration Statements related to the 2021 Plan are hereby incorporated by reference in and made part of this Registration Statement, except to the extent supplemented, superseded or modified by the specific information set forth below and/or the specific exhibits attached under Item 8 hereto, pursuant to Rule 412 under the Securities Act of 1933, as amended (the “Securities Act”).

In accordance with the instructional Note to Part I of Form S-8, the information specified by Part I of Form S-8 has been omitted from this Registration Statement for offers of common shares pursuant to the 2021 Plan. The documents containing the information specified in Part I will be delivered to the participants in the Plan as required by Rule 428(b)(1) under